Mirae Asset Global Etfs Holdings Ltd. Ionis Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 6,357 shares of IONS stock, worth $269,282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,357Holding current value
$269,282% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$587 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$535 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$437 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$350 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$278 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.01B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...